Works matching IS 00126667 AND DT 2023 AND VI 83 AND IP 17
Results: 7
Motixafortide: First Approval.
- Published in:
- Drugs, 2023, v. 83, n. 17, p. 1635, doi. 10.1007/s40265-023-01962-w
- By:
- Publication type:
- Article
Mitapivat: A Review in Pyruvate Kinase Deficiency in Adults.
- Published in:
- Drugs, 2023, v. 83, n. 17, p. 1613, doi. 10.1007/s40265-023-01961-x
- By:
- Publication type:
- Article
Sunvozertinib: First Approval.
- Published in:
- Drugs, 2023, v. 83, n. 17, p. 1629, doi. 10.1007/s40265-023-01959-5
- By:
- Publication type:
- Article
Current Medical Therapy for Adenomyosis: From Bench to Bedside.
- Published in:
- Drugs, 2023, v. 83, n. 17, p. 1595, doi. 10.1007/s40265-023-01957-7
- By:
- Publication type:
- Article
Elranatamab: First Approval.
- Published in:
- Drugs, 2023, v. 83, n. 17, p. 1621, doi. 10.1007/s40265-023-01954-w
- By:
- Publication type:
- Article
The Place of Cannabinoids in the Treatment of Gynecological Pain.
- Published in:
- Drugs, 2023, v. 83, n. 17, p. 1571, doi. 10.1007/s40265-023-01951-z
- By:
- Publication type:
- Article
Current and Future Treatment Landscape for Idiopathic Pulmonary Fibrosis.
- Published in:
- Drugs, 2023, v. 83, n. 17, p. 1581, doi. 10.1007/s40265-023-01950-0
- By:
- Publication type:
- Article